FilingReader Intelligence
Hisoar Pharmaceutical launches 300m yuan share buyback program
August 5, 2025 at 09:10 AM UTC•By FilingReader AI
Zhejiang Hisoar Pharmaceutical began buying back shares on August 5, purchasing 850,000 shares for 5.3 million yuan at prices between 6.24-6.29 yuan per share.
The 12-month program targets acquiring 150-300 million yuan worth of shares for employee stock ownership plans and equity incentives.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002099•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Zhejiang Hisoar Pharmaceutical publishes news
Free account required • Unsubscribe anytime